Le Dr Julie Labrosse est auteure de nombreuses publications scientifiques consacrées à la médecine de la reproduction, à la fertilité et à la préservation de la fertilité. Retrouvez la liste complète et actualisée de ses travaux sur son profil ORCID.

Ouvrages scientifiques

Female and Male Fertility Preservation, Springer

Julie Labrosse, M. Grynberg, 2021

 

Long-term safety of Assisted Reproduction

Julie Labrosse, C. Sifer, 2021

 

Textbook of Assisted Reproductive Techniques

Julie Labrosse, M. Grynberg, 2022

 

Oncoplastoic Breast Surgery Techniques for the General Surgeon

F. Reyal, Julie Labrosse, 2020

Publications scientifiques

Outcomes of frozen embryo transfers from a large monocentric cohort (2982 cycles): towards a preferential use of cycles with a corpus luteum for endometrial preparation.

Labrosse J, Haab E, Entezami F, Massin N. – Front Endocrinol (Lausanne). 2026

 

The role of luteinizing hormone in the management of female infertility: A French Delphi consensus.

Cédrin-Durnerin I, Labrosse J, Bridoux CC, de Buyst V, Paillet S, Lubrano M, Cerceau T, Bouée S, Salle B, Olivennes F, Jacquesson L. – J Assist Reprod Genet. 2025
 

Impact of oxygen tension during in vitro maturation: a sibling-oocyte prospective double-blinded study.

Boumerdassi Y, Labrosse J, Hammami F, Dahoun M, Bouyer J, O’Neill L, Sarandi S, Peigné M, Cedrin I, Grynberg M, Sifer C. – Fertil Steril. 2024
 

Higher risk of pre-eclampsia and other vascular disorders with artificial cycle for frozen-thawed embryo transfer compared to ovulatory cycle or to fresh embryo transfer following in vitro fertilization.

Epelboin S, Labrosse J, De Mouzon J, Devaux A, Gervoise-Boyer MJ, Hesters L, Jonveaux P, Levy R, Sermondade N, Fauque P, Pessione F. – Front Endocrinol (Lausanne). 2023

 

Fetal growth disorders following medically assisted reproduction: due to maternal context or techniques? A national French cohort study.

Sermondade N, Hesters L, De Mouzon J, Devaux A, Epelboin S, Fauque P, Gervoise-Boyer MJ, Labrosse J, Viot G, Bergère M, Devienne C, Jonveaux P, Levy R, Pessione F. – Reprod Biomed Online. 2023
 

Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network).

Sebbag C, Rousset-Jablonski C, Coussy F, Ray-Coquard I, Garin C, Evrevin C, Cessot M, Labrosse J, Laot L, Darrigues L, Bobrie A, Sénéchal-Davin C, Espié M, Giacchetti S, Plu-Bureau G, Maitrot-Mantelet L, Gompel A, Santulli P, Asselain B, Hotton J, Coutant C, Guerin J, Decanter C, Mailliez A, Brain E, Dumas E, Sablone L, Seintinelles RN, Reyal F, Hamy AS. – Breast. 2023

Fertility of tomorrow: Are there any restrictions left?

Labrosse J, Grynberg M. – Ann Endocrinol (Paris). 2022
 

Impact of endometrial preparation on early pregnancy loss and live birth rate after frozen embryo transfer: a large multicenter cohort study (14 421 frozen cycles).

Vinsonneau L, Labrosse J, Porcu-Buisson G, Chevalier N, Galey J, Ahdad N, Ayel JP, Rongières C, Bouet PE, Mathieu d’Argent E, Cédrin-Durnerin I, Pessione F, Massin N. – Hum Reprod Open. 2022
 

Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?

Lalami I, Labrosse J, Cedrin-Durnerin I, Comtet M, Vinolas C, Krief F, Sifer C, Peigne M, Grynberg M. – Reprod Biol Endocrinol. 2022
 

Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors.

Mangiardi-Veltin M, Sebbag C, Rousset-Jablonski C, Ray-Coquard I, Berkach C, Laot L, Wang Y, Abdennebi I, Labrosse J, Sautter C, Toussaint A, Sablone L, Laas E, Khallouch S, Coussy F, Santulli P, Chapron C, Bobrie A, Jacot W, Sella N, Dumas E, Sénéchal-Davin C, Espie M, Giacchetti S, Maitrot L, Plu-Bureau G, Coutant C, Guerin J, Asselain B, Fumoleau P, Rodrigues M, Decanter C, Mailliez A, Delrieu L, Lemoine A, Jouannaud C, Houdre D, Reyal F, Hamy AS; Seintinelles Research Network. –  Reprod Biomed Online. 2022
 

Women utilizing oocyte donation have a decreased live birth rate if they displayed a low progesterone level in a previous hormonal replacement mock cycle.

Labrosse J, Peigné M, Eustache F, Sifer C, Grynberg M, Cedrin-Durnerin I. – J Assist Reprod Genet. 2021
 

Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women?

Grynberg M, Labrosse J, Bennani Smires B, Sifer C, Peigne M, Sonigo C. – Hum Reprod. 2021
 

Impact of oxygen tension according to embryo stage of development: a prospective randomized study.

Herbemont C, Labrosse J, Bennani-Smires B, Cedrin-Durnerin I, Peigne M, Sermondade N, Sarandi S, Vivot A, Vicaut E, Talib Z, Grynberg M, Sifer – C.Sci Rep. 2021 
 

Endometriosis and assisted reproductive techniques independently related to mother-child morbidities: a French longitudinal national study.

Epelboin S, Labrosse J, Fauque P, Levy R, Gervoise-Boyer MJ, Devaux A, Bergère M, de Vienne C, Jonveaux P, De Mouzon J, Pessione F. – Reprod Biomed Online. 2021 
 

Early embryo development anomalies identified by time-lapse system: prevalence and impacting factors.

Ferraretto X, Hammas K, Llabador MA, Gricourt S, Labrosse J, Lousqui J, Epelboin S, Tubiana S, Patrat C. – Reprod Biomed Online. 2021
 

The Presence of an In Situ Component on Pre-Treatment Biopsy Is Not Associated with Response to Neoadjuvant Chemotherapy for Breast Cancer.

Labrosse J, Morel C, Lam T, Laas E, Feron JG, Coussy F, Lae M, Reyal F, Hamy AS. – Cancers (Basel). 2021
 

Time to Pregnancy, Obstetrical and Neonatal Outcomes after Breast Cancer: A Study from the Maternity Network for Young Breast Cancer Patients.

Labrosse J, Lecourt A, Hours A, Sebbag C, Toussaint A, Laas E, Coussy F, Grandal B, Dumas E, Daoud E, Morel C, Feron JG, Faron M, Pierga JY, Reyal F, Hamy AS. – Cancers (Basel). 2021
 

Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore.

Laas E, Labrosse J, Hamy AS, Benchimol G, de Croze D, Feron JG, Coussy F, Balezeau T, Guerin J, Lae M, Pierga JY, Reyal F. – Br J Cancer. 2021 
 

Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.

Epelboin S, Labrosse J, De Mouzon J, Fauque P, Gervoise-Boyer MJ, Levy R, Sermondade N, Hesters L, Bergère M, Devienne C, Jonveaux P, Ghosn J, Pessione F. – PLoS Med. 2021
 

Comparison of stimulated versus modified natural cycles for endometrial preparation prior to frozen embryo transfer: a randomized controlled trial.

Labrosse J, Lobersztajn A, Pietin-Vialle C, Villette C, Dessapt AL, Jung C, Brussieux M, Bry-Gauillard H, Pasquier M, Massin N. – Reprod Biomed Online. 2020
 

Endometriosis and assisted reproductive techniques independently related to mother-child morbidities: a French longitudinal national study.

Epelboin S, Labrosse J, Fauque P, Levy R, Gervoise-Boyer MJ, Devaux A, Bergère M, de Vienne C, Jonveaux P, De Mouzon J, Pessione F. – Reprod Biomed Online. 2021
 

Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis.

Labrosse J, Osdoit M, Hamy AS, Coussy F, Pierga JY, Reyal F, Laas E. – PLoS One. 2020
 

Anti Müllerian Hormone: More than a biomarker of female reproductive function.

Victoria M, Labrosse J, Krief F, Cédrin-Durnerin I, Comtet M, Grynberg M. – J Gynecol Obstet Hum Reprod. 2019
 

Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria.

Grynberg M, Labrosse J. – Front Endocrinol (Lausanne). 2019
 

Text Mining in Electronic Medical Records Enables Quick and Efficient Identification of Pregnancy Cases Occurring After Breast Cancer.

Labrosse J, Lam T, Sebbag C, Benque M, Abdennebi I, Merckelbagh H, Osdoit M, Priour M, Guerin J, Balezeau T, Grandal B, Coussy F, Bobrie A, Ferrer L, Laas E, Feron JG, Reyal F, Hamy AS. – JCO Clin Cancer Inform. 2019
 

A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.

Scheffer JB, Scheffer BB, Carvalho RF, Aguiar AP, Lozano DHM, Labrosse J, Grynberg M. – JBRA Assist Reprod. 2019
 

Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy.

Labrosse J, Abdennebi I, Thibault L, Laas E, Merckelbagh H, Morel C, Lam T, Lae M, Reyal F, Hamy AS. – Breast. 2018
    •